DermaRite Industries, LLC has issued a voluntary recall of various products due to potential contamination with Burkholderia cepacia, a microorganism known to cause severe infections, especially in individuals with weakened immune systems. The recall encompasses multiple lots of DermaKleen, DermaSarra, KleenFoam, and PeriGiene items that were distributed across the United States and Puerto Rico. Burkholderia cepacia infections can be life-threatening, as highlighted by the Centers for Disease Control and Prevention (CDC), emphasizing the critical nature of this recall to prevent potential health risks.
DermaKleen, one of the affected products, is an over-the-counter antiseptic lotion soap infused with Vitamin E, primarily used for handwashing to reduce bacteria on the skin. Similarly, DermaSarra functions as an over-the-counter external analgesic designed for temporary relief of itching resulting from minor skin irritations. KleenFoam, another recalled item, stands as an over-the-counter antimicrobial foam soap containing Aloe Vera, ideal for handwashing, particularly after changing diapers or tending to ill individuals. Lastly, PeriGiene, an over-the-counter antiseptic cleanser intended for use in the perineal area, is also included in the recall.
The specific products subject to the recall are identified by unique reorder numbers and lot numbers, with expiration dates falling between July 2025 and January 2027. DermaRite has promptly instructed its distributors and customers to thoroughly inspect their inventory and dispose of any affected products to prevent potential exposure to Burkholderia cepacia. While there have been no reported adverse events associated with the recalled products, the company is taking proactive measures to ensure consumer safety and well-being.
Consumers who have purchased the recalled products are encouraged to reach out to DermaRite Industries at 973-569-9000 extension 104 or via email for any inquiries they may have. Additionally, any adverse reactions or issues related to product quality can be reported online through the FDA’s MedWatch Adverse Event Reporting program. This streamlined process enables swift identification and resolution of any potential concerns related to the contaminated products, emphasizing the importance of transparent communication and collaboration between the manufacturer and consumers.
In conclusion, the voluntary recall of the DermaKleen, DermaSarra, KleenFoam, and PeriGiene products underscores the critical role of stringent quality control measures in ensuring the safety and efficacy of consumer goods. By swiftly addressing the issue of Burkholderia cepacia contamination, DermaRite Industries exemplifies its commitment to consumer well-being and product safety. This incident serves as a reminder of the importance of robust quality assurance protocols and rapid response strategies in the biotech industry to mitigate risks and uphold the highest standards of product integrity and safety.
Key Takeaways:
– Prompt voluntary recalls, such as the one initiated by DermaRite Industries due to Burkholderia cepacia contamination, are essential to safeguard consumer health and mitigate potential risks.
– Transparent communication channels between manufacturers and consumers, coupled with efficient reporting mechanisms like the FDA’s MedWatch Adverse Event Reporting program, are vital for swift resolution of product quality issues.
– The incident underscores the significance of robust quality control measures and proactive risk management strategies in the biotech industry to uphold product safety standards and ensure consumer well-being.
Read more on wftv.com